Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download CORPORATE BRIEF
Transcript
Monday 13th December 2004 Phase II Lecture theatre Corporate Brief 131204 Agenda • Clinical Governance and Developments (Keith Hyde) • People (Pat Zukowskyj) • PFI & Facilities (Pat Zukowskyj) • Finance (Pat Zukowskyj) • Fire Lecture ( Malcolm Dunlop) Corporate Brief 131204 Clinical Governance • Clinical Incidents – SIRT • IM & T – national programme • Pathology Modernisation – Capacity : community Diagnostics – Networks • Quality : CPA Jan 2006 & Service audits • CSB & Immunology Official Openings Corporate Brief 131204 Developments • Liquid based Cytology £500K + 500K (Y Wright) • National Hb Screening £100K (J Ardern) • SHO Training School £100K (C Hall/H Waters) • Better Blood Transfusion (J Ardern) • Infection Control eg Chlamydia £200K +(Professor Bolton) • EQA: Digital imaging (K Hyde/M Desai) • IVF & BNP developments Corporate Brief 131204 People • Consultant Contract (K Hyde) • Agenda for change (P Zukowskyj) • Communications (P Zukowskyj) • Healthcare Scientists (P Zukowskyj) • User Surveys (M Dunlop) Corporate Brief 131204 Facilities • PFI – CSB III Plans Corporate Brief 131204 Finance • Clinical & Scientific Support Services Division Overspent mainly due to extra lists in theatres, to try and get waiting lists down • Laboratory medicine underspent – Variance due mainly to pay – 70% – Rest due to internal recharging for our tests to other Directorate’s, and some external income • Directorates initial share of Divisional CRES target for the year (£80k) has been implemented • Directorate’s progress against our procurement target has yet to be assessed • Finance is the focus of the final Laboratory Managers meeting each month Corporate Brief 131204
